The new generation of the Barycela chickenpox vaccine is produced by GC Biopharma (Korea), using the MAV/06 vaccine.
The Barycela vaccine does not contain antibiotics in its ingredients due to technological improvements in the production process.
Chickenpox is a common infectious disease in children, especially in schools and kindergartens. According to health experts, although often considered a benign disease, chickpeas can still cause serious complications such as skin infections, pneumonia, encephalitis if not properly prevented.
Parents need to clearly understand that chickenpox is no longer a minor illness as many people once thought.
Up to now, many people have thought that children with chickenpox will have lifelong immunity, so vaccination is not needed.
However, doctors warn that the disease can re-infection and progress severely in children with delicate constitution, children forced to participate early in school environments (kindergarten, kindergarten, primary school) or children living in crowded environments.
Adequate and punctual vaccination of chickenpox is considered the most effective measure to protect children.
According to the World Health Organization (WHO), chickenpox vaccination significantly reduces the risk of disease and complications, while limiting the spread in the community.
In a recent updated guide on chickenpox vaccine, WHO confirmed that the MAV/06 chickenpox vaccine in the Barycela vaccine produced by GC Biopharma (Korea) is effective and safe, equivalent to traditional chickpea vaccines.
This helps diversify the supply of chickenpox vaccines for many countries around the world, including Vietnam, helping to be more proactive in disease prevention for children. At the same time, it also opens up more opportunities to access new-generation chickenpox vaccines, improved in production technology and meeting good quality standards.
In addition to the effectiveness and quality of vaccines, parents also tend to choose a safe vaccine for their children – a vaccine “without antibiotics”.
Because one of the concerns of parents is to minimize the risk of allergies or sensitivities in children for ingredients in vaccines, especially surplus antibiotics used in the production process.
According to experts, vaccines that do not use antibiotics in the production process can help parents feel more secure when vaccinating their children, especially for children with sensitive pathogens or a history of allergies.
Many parents are currently looking forward to accessing information about the new generation chickenpox vaccine to choose to vaccinate their children. And, the Barycela vaccine has been researched and produced with quality that meets safety and effectiveness standards according to international guidelines. Currently, the Barycela vaccine is available in Vietnam.
According to Dr. Le Phuoc Thi – Chairman and General Director of NAVIVA GROUP, the distributor of the Barycela chickenpox vaccine – bringing Barycela to the market is expected to add a suitable and reliable option for parents, in addition to chickenpox vaccines that have been widely used before.
Experts recommend that parents should consult a doctor and choose a vaccine suitable for their children’s physical condition, while following the recommended vaccination schedule to achieve optimal disease prevention results.
